Skip to main content

Table 2 Inhibitory effects assessed with the HLC assay

From: Characterization and optimization of the haemozoin-like crystal (HLC) assay to determine Hz inhibiting effects of anti-malarial compounds

μM

15.6

31.25

62.5

125

250

500

1000

P2.5

P10

P2.5

P10

P2.5

P10

P2.5

P10

P2.5

P10

P2.5

P10

P2.5

P10

Blood

 Chloroquine

+

+

+

+

 Amodiaquine

+

+

+

+

 Quinine

+

+

+

+

+

 Piperaquine

+

+

+

+

 Halofantrine

+

+

+

+

+

+

+

 Mefloquine

+

+

+

+

+

+

+

+

+

 Artemisinin

+

+

+

+

+

+

+

+

+

+

 Artesunate

+

+

+

+

+

+

+

 Doxycycline

+

+

+

+

+

+

+

+

+

+

+

 Rolitetracycline

+

+

+

+

+

+

+

+

+

 Tetracycline

+

+

+

+

+

+

+

+

+

+

+

 Pyrimethamine

+

+

+

+

+

+

+

+

+

+

+

+

+

+

 Gentamicin

+

+

+

+

+

+

+

+

+

+

Haemin

 Chloroquine

+

+

+

+

 Amodiaquine

+

+

+

+

 Quinine

+

+

+

+

+

+

 Piperaquine

+

+

+

+

+

 Halofantrine

+

+

+

+

+

+

+

+

 Mefloquine

+

+

+

+

+

+

+

+

+

 Artemisinin

+

+

+

+

+

+

+

 Artesunate

+

+

+

+

+

 Doxycycline

+

+

+

+

+

+

+

+

+

+

+

 Rolitetracycline

+

+

+

+

+

+

+

+

+

+

+

 Tetracycline

+

+

+

+

+

+

+

+

+

+

 Pyrimethamine

+

+

+

+

+

+

+

+

+

+

+

+

+

+

 Gentamicin

+

+

+

+

+

+

+

+

+

  1. Inhibitory effects of compounds assessed using the standard medium (see text for details). Doubling concentrations ranged from 15.6 to 1000 μM. Left columns (P2.5) contained pancreatin 4× USP at 2.5 % and right columns (P10) contained pancreatin 4× USP at 10 %. Top half to the table shows results using lysed blood and bottom half using haemin. Growth (+) and no growth (−)